This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction. Let’s explore!
Instead: Use disease-awareness campaigns focused on education rather than direct productpromotion. By optimizing bids, testing ad variations, and using ethical retargeting , pharma brands can increase ROI without regulatory risks. The challenge? Google and Facebook prohibit direct targeting based on medical conditions.
From detailed product information to open dialogue about potential side effects, transparency fosters trust and credibility. Its why companies like Johnson & Johnson emphasize educational content alongside productpromotions. Make sure everyone understands the legal and ethical boundaries of marketing in pharma.
Questionable, because before that I had started the internet healthcare ethics movement that Dr. Kap, what was his…. And so we started this coalition, and they work with pharmaceutical companies and others to develop this code of ethics. John Mack (PG): This is a code of ethics, the code of e-Health ethics, the e-Health Code of Ethics.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content